| |
Representative
publications |
1) G. Nappi, G. Bono, M.
Poloni, F. Savoldi.
Comparative DDS and ODG study in the occlusion of the ICA. Eur. Neurol.,
1977; 15: 102-108.
2) G. Nappi, F. Savoldi, G. Bono, E. Martignoni.
Reserpine - headache and PRL release in migraine. Headache, 1979,
19; 5: 273-277.
3) G. Nappi, F. Facchinetti, G. Bono, G. Micieli, D. Parrini, E. Martignoni,
F. Petraglia, A.R. Genazzani.
Plasma opioid levels in post-traumatic headache and trigeminal neuralgia.
Headache, 1982; 22: 276-276.
4) F. Tomasello, F. Mariani, C. Fieschi, C. Argentino, G. Bono, L.
De Zanche, D. Inzitari, A. Martini, P. Perrone, G. Sangiovanni.
Assessment of Inter-Observer Differences In The Italian Multicenter
Study on Reversibile Cerebral Ischemia. Stroke 1982, 13 (1):32-35.
5) G. Bono, G. Micieli, G. Sances, M. Calvani, G. Nappi.
L-SHTP treatment in primary headaches: an attempt at clinical identification
of responsive patients. Cephalalgia 1984; 4: 159-65.
6) G. Nappi, F. Petraglia, E. Martignoni, F. Facchinetti, G. Bono,
A.R. Genazzani.
Beta-endorphin CSF decrease in untreated parkinsonian patients. Neurology
1985, 35: 1371-1374
7) L. Candelise, M. Vigotti, C. Fieschi, G.L. Brambilla, G. Bono,
P. Conforti, L. De Zanche, D. Inzitari, F. Mariani, M. Prencipe, C.
Argentino, S. Passero. Italian Multicenter Study on Reversible Cerebral
Ischemic Attacks: VI Prognostic Factors and Follow-up Results. Stroke
1986; 17:842-8.
8) G.Nappi, F.Facchinetti, G. Bono, F.Petraglia, E. Sinforiani, A.R.
Genazzani
CSF and plasma levels of pro-opiomelanocortin-related peptides in
reversible ischaemic attacks and strokes. J.neurol. Neurosurg.Psychiat.1986;49:17-21.
9) G.Bono, N.Martucci, P.Merlo, R.Cerbo, G.Nappi, A.Agnoli.
Safety profile of flunarizine. A retrospective study in migraine and
cerebrovascular disorders. In : Calcium Antagonists:Pharmacology and
Clinical Research. Annals of the New York Academy of Sciences 1988;
522:712-715
10) R. Scelsi, A.P. Verri, G. Bono, A. Marbini.
Familial Amyloid Polineuropathy: report of an autopsy case with vitreous
opacities and polycystic kidney. Eur Neurol 1989, 29:27-32.
11) G.Bono, E.Sinforiani, P.Merlo, G.Belloni, M.Soldati, E.Gelso.
Alcoholic abstinence syndrome:short term treatment with metadoxine.
Int.J.Clin. Pharm.Res., 1991; XI-1: 35-40
12) E.Martignoni, G.Bono, F.Blandini, E.Sinforiani, P.Merlo, G.Nappi
Monoamines and related metabolite levels in the cerebrospinal fluid
of patients with dementia of Alzheimer type. Influence of treatment
with L-deprenyl. J Neural.Transm. , 1991; 3. 15-25
13) E.Sinforiani, M.Mauri, G.Bono, S.Muratori, E.Alessi, L.Minoli
Cognitive abnormalities and disease progression in a selected population
of asymptomatic HIV–positive subjects. AIDS , 1991; 5: 1117-1120
14) M. Mauri, E. Sinforiani, G. Bono, F. Vignati, M.E. Berselli, R.
Attanasio, G. Nappi.
Memory impairment in Cushing's disease. Acta Neurol. Scand. 1993;
87: 52-55.
15) M. Mauri, E. Sinforiani, S. Muratori, R. Zerboni, G. Bono.
Three-year neuropsychological follow-up in a selected group of HIV-infected
homosexual/bisexual men. AIDS, 1993, 7: 241-245.
16) M. Mauri, E. Sinforiani, F. Reverberi, P. Merlo, G. Bono.
Pramiracetam effects on scopolamine-induced amnesia in healthy volunteers.
Archives of Gerontology and Geriatrics 1994; 18: 133-139.
17) G. Bono, I. Neri, F. GranelIa, A.R. Genazzani, F. Facchinetti.
Factors associated with pain complaints in a clinical sample of postmenopausal
women. J. Psychosom. Obstet. Gynecol. 1995; 16: 117-121.
18) G. Bono, C. Balducci, P. Richelmi, G.E Koob, L. Pulvirenti.
Dopamine partial receptor agonists reduce ethanol intake in the rat.
European Journal of Pharmacology 1996; 296: 233-238.
19) G. Bono, M. Mauri, E. Sinforiani, G. Barbarini, L. Minoli, M.
Fea.
Longitudinal neuropsychological evaluation of HIV-infected intravenous
drug users. Addiction 1996; 91 (2):263-268.
20) D. Franciotta, E. Cardini, G. Bono, R. Brustia, L. Minoli, V.
Cosi.
Antigen-specific oligoclonal IgG in AIDS-related cytomegalovirus and
toxoplasma encephalitis. Acta Neurol Scand 1996, 94, 215-218.
21) G. Bono, F. Antonaci, G. Sandrini, E. Pucci, F. Rossi, G. Nappi.
Pain pressure threshold in cluster headache patients. Cephalalgia
1996; 16: 62-6.
22) A. Costa, G. Bono. E. Martignoni, P. Merlo, G. Sances. G. Nappi.
An assessment of hypothalamo-pituitary-adrenal axis functioning in
non-depressed, early abstinent alcoholics. Psychoneuroendocrinology
1996; 21: 263-275
23) R. Estruch, G. Bono, P. Laine, E. Antunez, A. Petrucci, C. Morocutti,
M. Hillbom. Brain Imaging in Alcoholism. European Journal of Neurology
1998, 5:119-135
24) R.E. Nappi, E. Sinforiani, M. Mauri, G. Bono, G. Nappi
Memory Functioning at Menopause: Impact of Age in Ovariectomized Women.
Gynecol Obstet Invest 1999;47:28-36
25) G. Bono, F. Antonaci, A. Dario, A.M. Clerici, S. Ghirmai, G. Nappi
Unilateral Headaches and their relationship with cervicogenic headache.
Clin. Exp. Rheumatol 2000:18 (suppl.19): S11-S15.
26) G. Bono, F. Antonaci, S. Ghirmai, F. D’Angelo, M. Berger,
G. Nappi
Whiplash injuries: clinical picture and diagnostic work-up. Clin.
Exp. Rheumatol 2000:18 (suppl.19): S23-S28
27) Bono G, Mauri M, Clerici AM, Raineri C, Nappi G.
Outcomes of Alzheimer patients in a special care unit: results of
a three year follow-up. Research and practice in Alzheimer Disease – Volume 5 – Serdi Publ, Paris 2001, pp 232-236
28) E. Sinforiani, R. Curci, R. Fancellu, P. Fachinetti, T. Mille,
G. Bono
Neuropsychological changes after carotid endoarterectomy. Functional
Neurology, 2001; 16(4):329-336
29) F. Blandini, G. Nappi, R. Fancellu,
A. Mangiagalli, A. Samuele, G. Riboldazzi, D. Calandrella, C. Pacchetti, G. Bono, E. Martignoni. Modifications
of plasma and platelet levels of L-DOPA and its direct metabolites
during treatment with tolcapone or entacapone in patients with Parkinson’s
disease. J Neural Transm, 2003, 110:911-922.
30) O. Siaastad, T.A. Fredriksen, G. Bono, G. Nappi. Cervicogenic
Headaches - Basic Concepts. EHF Europen Headache Federation, Smith-Gordon,
London, 2003
ISBN I-85463-223-x |
